Table IV. List of compounds that are decreased in abundance in C2-Idf leaves.
For each compound, its unique number (No.), m/z, retention time (RT), peak area (as mean ± sd), and ratio of the peak area in C2 and C2-Idf are given. inf, Infinite. MS/MS-based structural characterization is given in Supplemental File S1.
No. |
m/z |
RT (min) |
Name |
Peak Area, C2 |
Peak Area, C2-Idf |
Ratio, C2/C2-Idf |
---|---|---|---|---|---|---|
Flavones | ||||||
2 | 547.1454 | 10.00 | Apigenin-6C-deoxyhexoside-8C-pentoside | 1,770 ± 3,555 | 1,054 ± 268 | 16 |
3 | 547.1457 | 10.63 | Apigenin-6C-deoxyhexose-8C-pentoside | 43,830 ± 10,877 | 2,118 ± 452 | 21 |
5 | 561.1601 | 12.69 | Apigenin-6C,8C-dideoxyhexoside 2 | 8,953 ± 2,355 | 538 ± 309 | 17 |
6 | 563.1405 | 7.08 | Apigenin-6C-hexoside-8C-pentoside | 289,600 ± 64,693 | 5,024 ± 1,453 | 58 |
7 | 577.1553 | 8.36 | Apigenin-6C-hexoside-8C-deoxyhexoside 1 | 31,880 ± 6,590 | 293 ± 133 | 109 |
8 | 577.1557 | 8.88 | Apigenin-6C-hexoside-8C-deoxyhexoside 2 | 45,078 ± 9,786 | 587 ± 238 | 77 |
9 | 577.1556 | 9.04 | Apigenin-6C-hexoside-8C-deoxyhexoside 3 | 39,304 ± 8,518 | 217 ± 56 | 181 |
10 | 593.1493 | 5.95 | Apigenin-6C,8C-dihexoside | 194,461 ± 42,585 | 4,538 ± 1,082 | 43 |
44 | 593.1502 | 6.77 | Apigenin-C-hexoside + hexose | 7,521 ± 1,510 | 31 ± 27 | 244 |
45 | 447.0955 | 7.02 | Luteolin-C-hexoside | 30,524 ± 9,242 | 1,589 ± 182 | 19 |
46 | 579.1343 | 6.15 | Luteolin-6C-hexoside-8C-pentoside | 13,356 ± 4,131 | 2 ± 4 | 8,203 |
47 | 593.1507 | 7.13 | Luteolin-C-hexoside + deoxyhexose | 14,903 ± 2,980 | 182 ± 92 | 82 |
48 | 651.1179 | 8.50 | Chrysoeriol + hexuronic acid + hexuronic acid | 13,558 ± 2,317 | 1,100 ± 529 | 12 |
11 | 491.1213 | 9.94 | Tricin-O-hexoside 1 | 16,812 ± 4,302 | 823 ± 131 | 20 |
12 | 491.1208 | 11.40 | Tricin-O-hexoside 2 | 17,680 ± 4,715 | 495 ± 153 | 36 |
13 | 403.1057 | 15.49 | Tricin + glycerol | 8,511 ± 2,242 | 5 ± 14 | 1,621 |
25 | 667.1479 | 9.59 | Tricin + hexuronic acid + hexose 1 | 11,573 ± 3,063 | 951 ± 423 | 12 |
49 | 667.1498 | 9.36 | Tricin + hexuronic acid + hexose 2 | 33,817 ± 6,894 | 2,334 ± 661 | 14 |
14 | 637.1389 | 10.87 | Tricin + hexuronic acid + pentose | 20,469 ± 5,449 | 1,185 ± 496 | 17 |
17 | 813.1832 | 13.41 | Tricin + hexuronic acid + pentose + ferulic acid | 15,008 ± 3,821 | 1,450 ± 537 | 10 |
Flavonols | ||||||
27 | 593.1499 | 8.85 | Kaempferol-O-hexoside + deoxyhexose | 136,928 ± 31,412 | 199 ± 41 | 688 |
49 | 609.1452 | 7.74 | Quercitin-O-hexoside + deoxyhexoside | 20,081 ± 3,690 | 525 ± 196 | 38 |
Hexosylated flavonolignols | ||||||
50 | 657.1798 | 14.74 | Tricin(4′-O-β)H-γ/α/4-Ο-hexoside | 19,127 ± 4,975 | 47 ± 28 | 408 |
28 | 687.1894 | 12.17 | Tricin(4′-O-β)G-5/7-O-hexoside 1 | 19,765 ± 5,627 | 0 ± 0 | inf |
29 | 687.1891 | 12.86 | Tricin(4′-O-β)G-5/7-O-hexoside 2 | 18,526 ± 5,906 | 3 ± 8 | 5,993 |
30 | 687.1900 | 13.59 | Tricin(4′-O-β)G-5/7-O-hexoside 3 | 17,549 ± 5,108 | 4 ± 12 | 3,965 |
31 | 687.1895 | 14.18 | Tricin(4′-O-β)G-γ/α/4-O-hexoside 1 | 68,867 ± 17,163 | 11 ± 15 | 6,275 |
51 | 687.1901 | 14.80 | Tricin(4′-O-β)G-γ/α/4-O-hexoside 2 | 46,488 ± 10,726 | 58 ± 18 | 806 |
Flavonolignols | ||||||
52 | 495.1309 | 17.65 | Tricin(4′-O-β)H 1 | 11,193 ± 2,943 | 4 ± 4 | 2,653 |
53 | 495.1310 | 18.36 | Tricin(4′-O-β)H 2 | 12,388 ± 3,166 | 3 ± 4 | 4,177 |
54 | 525.1408 | 18.01 | Tricin(4′-O-β)G 1 | 93,393 ± 24,017 | 17 ± 17 | 5,614 |
55 | 525.1411 | 18.77 | Tricin(4′-O-β)G 2 | 75,740 ± 17,902 | 2 ± 5 | 42,988 |
56 | 539.1562 | 21.74 | Tricin(4′-O-β)G-α-O-methyl | 6,914 ± 3,117 | 10 ± 27 | 675 |
57 | 567.1497 | 22.13 | Tricin(4′-O-β)G-γ-O-acetyl | 9,341 ± 4,185 | 2 ± 6 | 4,472 |
33 | 721.2093 | 16.18 | Tricin(4′-O-β)G(4-O-β)G 1 | 14,826 ± 5,233 | 10 ± 12 | 1,558 |
34 | 721.2097 | 16.88 | Tricin(4′-O-β)G(4-O-β)G 2 | 20,322 ± 6,742 | 5 ± 14 | 3,873 |
58 | 721.2097 | 16.43 | Tricin(4′-O-β)G(4-O-β)G 3 | 9,059 ± 3,083 | 0 ± 0 | inf |
59 | 721.2096 | 17.07 | Tricin(4′-O-β)G(4-O-β)G 4 | 10,052 ± 3,231 | 5 ± 8 | 2,131 |
60 | 721.2096 | 17.34 | Tricin(4′-O-β)G(4-O-β)G 5 | 22,808 ± 7,483 | 1 ± 3 | 20,696 |